Related Experiment Video
Updated: Jan 24, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association
Insights
Pediatric cardiomyopathy, a serious heart muscle disease in children, requires better diagnostic approaches. Early diagnosis and research are crucial for improving outcomes and quality of life for affected children.
Area of Science:
- Pediatric Cardiology
- Cardiomyopathy Research
- Genetics of Heart Disease
Background:
- Cardiomyopathy (heart muscle disease) in children leads to poor outcomes, with nearly 40% dying or needing heart transplantation within two years of diagnosis.
- Pediatric cardiomyopathy is the leading cause of heart transplantation for children over one year of age, with no decline in transplant rates over the past decade.
- Despite a significant impact, research and focus on pediatric cardiomyopathy lag behind that of comparable childhood cancers.
Purpose of the Study:
- To provide the most current understanding of the causes of cardiomyopathy in children.
- To outline optimal diagnostic approaches for pediatric cardiomyopathy.
- To guide future research priorities for earlier diagnosis and improved outcomes in pediatric cardiomyopathy.
Main Methods:
- Review of current scientific understanding and expert consensus on pediatric cardiomyopathy.
- Analysis of data from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry.
- Focus on diagnostic criteria and classification of pediatric cardiomyopathy.
Main Results:
- Genetic causes are suspected in most pediatric cardiomyopathy cases, though established in few.
- The incidence of pediatric cardiomyopathy is approximately 1 in 100,000 children.
- Current diagnostic understanding and research efforts are insufficient given the severity of the condition.
Conclusions:
- There is a critical need for enhanced focus on the diagnosis and classification of pediatric cardiomyopathy.
- Earlier diagnosis and targeted research are essential to improve clinical outcomes and quality of life.
- This statement aims to stimulate future research to address the challenges posed by pediatric cardiomyopathy.
Abstract:
In this scientific statement from the American Heart Association, experts in the field of cardiomyopathy (heart muscle disease) in children address 2 issues: the most current understanding of the causes of cardiomyopathy in children and the optimal approaches to diagnosis cardiomyopathy in children. Cardiomyopathies result in some of the worst pediatric cardiology outcomes; nearly 40% of children who present with symptomatic cardiomyopathy undergo a heart transplantation or die within the first 2 years after diagnosis. The percentage of children with cardiomyopathy who underwent a heart transplantation has not declined over the past 10 years, and cardiomyopathy remains the leading cause of transplantation for children >1 year of age. Studies from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry have shown that causes are established in very few children with cardiomyopathy, yet genetic causes are likely to be present in most. The incidence of pediatric cardiomyopathy is ≈1 per 100 000 children. This is comparable to the incidence of such childhood cancers as lymphoma, Wilms tumor, and neuroblastoma. However, the published research and scientific conferences focused on pediatric cardiomyopathy are sparcer than for those cancers. The aim of the statement is to focus on the diagnosis and classification of cardiomyopathy. We anticipate that this report will help shape the future research priorities in this set of diseases to achieve earlier diagnosis, improved clinical outcomes, and better quality of life for these children and their families.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Scientific Laws and Theories
The Scientific Method
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
The Scientific Method
Heart Failure IV: Classification and Diagnostic Evaluation

